IRIS
CANNAVO', Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.482
EU - Europa 13.762
AS - Asia 7.263
SA - Sud America 2.593
Continente sconosciuto - Info sul continente non disponibili 793
AF - Africa 197
OC - Oceania 15
Totale 39.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.144
RU - Federazione Russa 7.004
SG - Singapore 3.046
BR - Brasile 2.210
CN - Cina 2.048
IE - Irlanda 1.517
SE - Svezia 1.204
IT - Italia 1.149
HK - Hong Kong 814
DE - Germania 604
FR - Francia 470
VN - Vietnam 440
UA - Ucraina 428
PL - Polonia 406
GB - Regno Unito 368
FI - Finlandia 289
IN - India 173
CA - Canada 137
AR - Argentina 132
BD - Bangladesh 124
MX - Messico 95
TR - Turchia 75
IQ - Iraq 70
EC - Ecuador 65
ID - Indonesia 65
JP - Giappone 58
NL - Olanda 53
AT - Austria 51
PK - Pakistan 51
UZ - Uzbekistan 51
ZA - Sudafrica 48
CO - Colombia 46
VE - Venezuela 44
BE - Belgio 43
ES - Italia 40
MA - Marocco 40
CZ - Repubblica Ceca 28
MY - Malesia 28
CL - Cile 26
AE - Emirati Arabi Uniti 23
KE - Kenya 23
PE - Perù 23
CR - Costa Rica 22
TN - Tunisia 22
PH - Filippine 20
SA - Arabia Saudita 20
JM - Giamaica 19
PY - Paraguay 18
JO - Giordania 16
CI - Costa d'Avorio 15
NP - Nepal 15
UY - Uruguay 14
IL - Israele 13
KG - Kirghizistan 13
OM - Oman 13
AZ - Azerbaigian 12
DZ - Algeria 12
LT - Lituania 12
AL - Albania 11
AU - Australia 11
BO - Bolivia 11
NI - Nicaragua 11
KZ - Kazakistan 10
EE - Estonia 9
SN - Senegal 9
TT - Trinidad e Tobago 9
GR - Grecia 8
GT - Guatemala 8
MD - Moldavia 8
SV - El Salvador 8
HN - Honduras 7
HU - Ungheria 7
LK - Sri Lanka 7
DO - Repubblica Dominicana 6
EG - Egitto 6
PA - Panama 6
RS - Serbia 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
LB - Libano 5
LV - Lettonia 5
NO - Norvegia 5
QA - Qatar 5
TH - Thailandia 5
XK - ???statistics.table.value.countryCode.XK??? 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
HR - Croazia 4
KH - Cambogia 4
KR - Corea 4
KW - Kuwait 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BB - Barbados 3
BG - Bulgaria 3
BH - Bahrain 3
Totale 38.264
Salva come PNG Salva come JPEG
Città #
Ashburn 2.137
Moscow 2.085
Singapore 1.673
Dublin 1.516
Chandler 1.236
Dallas 1.091
San Jose 970
Jacksonville 918
Hong Kong 809
Nyköping 695
Beijing 660
Council Bluffs 482
Warsaw 388
Messina 371
The Dalles 366
Los Angeles 296
Princeton 291
Dearborn 274
Lauterbourg 259
Medford 234
Cambridge 228
Des Moines 209
New York 181
Munich 175
São Paulo 170
Buffalo 156
Ann Arbor 136
Boardman 134
Santa Clara 130
Ho Chi Minh City 122
Lancaster 112
Tianjin 109
Wilmington 91
Hanoi 86
Shenyang 72
Rio de Janeiro 71
Belo Horizonte 68
Redondo Beach 66
Columbus 65
Rome 65
Jinan 63
Frankfurt am Main 62
Brooklyn 61
San Mateo 60
Nanjing 59
Orem 59
Guangzhou 57
Dong Ket 56
Atlanta 54
Houston 53
Seattle 52
Tashkent 48
Hyderabad 46
Tokyo 46
Helsinki 45
Woodbridge 44
Phoenix 42
Brussels 40
Denver 40
Milan 40
Haikou 39
Shanghai 39
Chicago 38
London 38
Nuremberg 37
Jakarta 36
Catania 35
Curitiba 35
Hebei 35
Brasília 34
Turku 33
Mexico City 32
Montreal 32
Zhengzhou 32
Hangzhou 31
Porto Alegre 31
Vienna 31
Bremen 30
Shenzhen 30
Nanchang 29
Manchester 28
Chennai 27
Johannesburg 27
Amsterdam 26
Baghdad 26
Stockholm 26
Ningbo 25
Toronto 24
Turin 24
Campinas 22
Pune 22
San Francisco 22
Washington 22
Fortaleza 20
Nairobi 20
Quito 20
Ribeirão Preto 20
Salvador 20
Ankara 19
Bogotá 19
Totale 21.360
Salva come PNG Salva come JPEG
Nome #
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 318
Effects of cyberknife radiotherapy treatment of pituitary adenomas 298
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study 295
Aggressive pituitary adenomas: the dark side of the moon 284
La chirurgia tiroidea transorale 284
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 255
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 251
Oral mucositis induced by treatment with soft gel formulation of levothyroxine 234
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 232
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 227
Acne ed irsutismo: patologie endocrine? 219
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 217
A 53-year-old woman with Cushing's disease and a pituitary tumor 217
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 212
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 209
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 207
Global Cushing's disease epidemiology: a systematic review and meta-analysis of observational studies 206
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 203
L’apoplessia ipofisaria: riconoscerla rapidamente e trattarla correttamente. 201
Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella 199
Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women 199
A case of clinically silent acromegaly with erectile dysfunction. 199
Global epidemiology of acromegaly: A systematic review and meta-analysis 189
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 188
Acromegaly is associated with increased cancer risk: a survey in Italy 186
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 185
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 185
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 185
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 184
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 184
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 183
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 182
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 182
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 181
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 181
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 181
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR)in a patient with glucocorticoid resistance 180
Increased prevalence of acromegaly in a highly polluted area. 180
Analisi dell'intervallo QT all'ECG di superficie in pazienti affetti da deficit primario di GH con e senza ipertrofia ventricolare sinistra 178
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 177
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 176
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 175
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 175
Oxidative stress as a key feature of autoimmune thyroiditis: an update 175
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 174
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 173
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 172
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 172
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 171
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 170
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 169
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 168
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 168
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 168
Course of pregnancies in women with Cushing's disease treated by gamma-knife 167
Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study 165
Atrial parasystole in left ventricular noncompaction: a morphofunctional study by echocardiography and magnetic resonance imaging. 165
Adrenal Cushing Syndrome: Diagnosis and Management in a 10-Year-Old Boy with Carney Complex 164
Predictive markers of recurrence in radically resected pituitary macroadenomas 164
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 161
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 161
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 160
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 158
A novel point mutation in the ligand-binding domain of the human glucocorticoid receptor (hGR) in a patient with glucocorticoid resistance. 158
MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients. 157
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 157
Multidisciplinary management of pituitary apoplexy 156
Modificazione del pattern secretivo, dopo chirurgia, e dei marker proliferativi cellulari, dopo radioterapia (gamma-knife), in un corticotropinoma invasivo. 155
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 155
Subcutaneous lipoatrophy induced by long-term pegvisomant administration in a patient with acromegaly. 154
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 154
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 153
Environmental Endocrinology and Endocrine Disruptors: Environmental Impact on the Hypothalamus–Pituitary Axis 152
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 152
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography 151
Adrenocorticotropin responsiveness to acute octreotide administration is not affected by mifepristone premedication in patients with Cushing's disease. 151
Commentary on "Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas" 151
Thyroid nodules in growth hormone replaced patients. 151
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 151
Osilodrostat (LCI699) per la cura della sindrome di Cushing 150
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 149
Cystic Fibrosis as a Cause of Malabsorption and Increased Requirement of Levothyroxine 148
Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cells 147
How to improve effectiveness of pegvisomant treatment in acromegalic patients 146
Increased interleukin 22 circulating levels in patients with tumors involving the hypothalamic-pituitary region 146
Peptide receptor radionuclide therapy (PRRT) in patients with giant aggressive pituitary tumors: experience of an Italian referral center and review of literature 146
A New Clinical Model to Estimate the Pre-Test Probability of Cushing’s Syndrome: The Cushing Score 146
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. 145
Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study 144
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 144
Pituitary atypical teratoid rhabdoid tumor in a patient with prolactinoma: A unique description 143
An unusual case of idiopathic hyperprolactinemia 142
Temozolomide-induced shrinkage of a pituitary carcinoma. 141
Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea 141
Effects Of Epigenetic Changes In Gstp1 And Mgmt Gene On Clinicopathological Fatures Of Acromegaly Patients 140
Modificazione dei parametri di rischio cardiovascolare durante trattamento sostitutivo prolungato con ormone della crescita 139
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 139
Increased serum brain natriuretic peptide levels are a major predictor of myocardial hypertrophy in acromegalic patients. 139
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis. 139
Correlation between endocrinological parameters and acne severity in adult women 138
Totale 17.798
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.434 0 0 0 95 50 23 85 75 41 205 243 617
2022/20234.670 394 357 202 384 323 477 88 295 1.847 47 197 59
2023/20241.199 111 213 98 108 111 212 20 104 4 65 7 146
2024/20256.031 101 83 162 316 337 139 171 1.308 1.563 382 473 996
2025/202617.128 773 1.038 1.298 1.050 1.482 3.708 2.167 2.021 2.080 779 347 385
2026/20273.064 542 1.358 1.033 131 0 0 0 0 0 0 0 0
Totale 39.105